← Leaderboards
Kris Kowdley
University Of Washington
$16,222,064
Attributed
$18,144,621
Total exposure
29
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,144,621 · 29
By mechanism
U01$11,616,075 · 2
R01$2,498,537 · 1
R21$1,745,038 · 5
K24$1,493,013 · 1
R56$441,361 · 1
M01$278,237 · 18
Top collaborators
- Robert L Carithers6 shared
- Brian James Mcmahon6 shared
Most similar at University Of Washington
Same institution · by research overlap
- Hugh Barret$111,316
- Robert Henry Knopp$3,279,685
- Akiko Okifuji$5,845,621
- Robert L Carithers$2,068,652
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchLiver DiseasesIronLiverFundingNatural HistoryHuman SubjectNonalcoholic SteatohepatitisResourcesPathogenesisAdultDatabasesNon-Alcoholic Fatty LiverUnited States National Institutes Of HealthResearch PersonnelSuccessEnrollmentChildHepaticClinical TrialsMedical CenterStagingAncillary StudyHuman Therapy Evaluation
Grant awards (107)
Clinical Research Network in Nonalcoholic Steatohepatitis$249,189
U01 · FY2025 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$250,000
U01 · FY2024 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$215,503
U01 · FY2023 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$398,912
U01 · FY2022 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$333,873
U01 · FY2021 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$452,213
U01 · FY2020 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$353,363
U01 · FY2019 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$85,371
U01 · FY2018 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$341,398
U01 · FY2017 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$94,808
U01 · FY2016 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$192,384
U01 · FY2015 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$41,830
U01 · FY2015 · DK · contact PI
The Role of Iron in the Pathogenesis of NAFLD$318,463
R01 · FY2014 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$221,608
U01 · FY2014 · DK · contact PI
Novel prognostic microRNA biomarkers for primary sclerosing cholangitis$163,256
R21 · FY2014 · DK · contact PI
The Role of Iron in the Pathogenesis of NAFLD$159,836
R01 · FY2014 · DK · contact PI
Novel prognostic microRNA biomarkers for primary sclerosing cholangitis$78,197
R21 · FY2014 · DK · contact PI
Clinical Research Network in Nonalcoholic Steatohepatitis$1,002
U01 · FY2014 · DK · contact PI
The Role of Iron in the Pathogenesis of NAFLD$611,754
R01 · FY2013 · DK · contact PI
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska$596,988
U01 · FY2013 · DK
Novel prognostic microRNA biomarkers for primary sclerosing cholangitis$275,057
R21 · FY2013 · DK · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$206,737
U01 · FY2013 · DK · contact PI
Serum Biomarkers Associated With Phenotypic Expression of Hemochromatosis.$121,880
R21 · FY2013 · HL · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$105,119
U01 · FY2013 · DK · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$102,377
U01 · FY2013 · DK · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$60,279
U01 · FY2013 · DK · contact PI
The Role of Iron in the Pathogenesis of NAFLD$635,347
R01 · FY2012 · DK · contact PI
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska$545,775
U01 · FY2012 · DK
Clinical Research Network in Non-Alcoholic Steatohepatitis$291,944
U01 · FY2012 · DK · contact PI
Serum Biomarkers Associated With Phenotypic Expression of Hemochromatosis.$128,025
R21 · FY2012 · HL · contact PI
The Role of Iron in the Pathogenesis of NAFLD$773,137
R01 · FY2011 · DK · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$446,055
U01 · FY2011 · DK · contact PI
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska$437,657
U01 · FY2011 · DK
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska$641,174
U01 · FY2010 · DK
The Role of Iron in the Pathogenesis of NAFLD$441,361
R56 · FY2010 · DK · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$385,754
U01 · FY2010 · DK · contact PI
Patient Oriented Research & Mentoring in liver diseases$176,079
K24 · FY2010 · DK · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$150,000
U01 · FY2010 · DK · contact PI
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska$507,735
U01 · FY2009 · DK
Patient Oriented Research & Mentoring in liver diseases$176,079
K24 · FY2009 · DK · contact PI
Patient Oriented Research & Mentoring in liver diseases$54,000
K24 · FY2009 · DK · contact PI
Clinical Research Network in Non-Alcoholic Steatohepatitis$15,561
U01 · FY2009 · DK · contact PI
Clinical Research Network in Non Alcoholic Steatohepatitis$834,264
U01 · FY2008 · DK · contact PI
Patient Oriented Research & Mentoring in liver diseases$176,079
K24 · FY2008 · DK · contact PI
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska$154,507
U01 · FY2008 · DK
Clinical Research Network in Non Alcoholic Steatohepatitis$224,394
U01 · FY2007 · DK · contact PI
Patient Oriented Research & Mentoring in liver diseases$176,079
K24 · FY2007 · DK · contact PI
Clinical Research Network in Non Alcoholic Steatohepatitis$127,284
U01 · FY2007 · DK · contact PI
TREATMENT OF NONALCHOLIC STEATOHEPATITIS$19,638
M01 · FY2007 · RR · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$5,406
M01 · FY2007 · RR · contact PI
IRON DEPLETION THERAPY FOR PTS WITH TYPE 2 DM AND NAFLD$1,447
M01 · FY2007 · RR · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) REGISTRY AND TISSUE REPOSITORY$1,143
M01 · FY2007 · RR · contact PI
A RANDOMIZED, MASKED, CONTROLLED STUDY OF OMEGA-3 POLYUNSATURATED FATTY ACID$609
M01 · FY2007 · RR · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$305
M01 · FY2007 · RR · contact PI
Clinical Research Network in Non Alcoholic Steatohepati*$597,913
U01 · FY2006 · DK · contact PI
Patient Oriented Research & Mentoring in liver diseases$176,079
K24 · FY2006 · DK · contact PI
Room Temp Susceptometry For Hepatic Iron Measurement$141,038
R21 · FY2006 · DK · contact PI
TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (PIVENS)$90,969
M01 · FY2006 · RR · contact PI
Room Temp Susceptometry For Hepatic Iron Measurement$86,589
R21 · FY2006 · DK · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$54,581
M01 · FY2006 · RR · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$15,712
M01 · FY2006 · RR · contact PI
A RANDOMIZED, MASKED, CONTROLLED STUDY OF OMEGA-3 POLYUNSATURATED FATTY ACID$12,405
M01 · FY2006 · RR · contact PI
Clinical Research Network in Non Alcoholic Steatohepati*$454,224
U01 · FY2005 · DK
Room Temp Susceptometry For Hepatic Iron Measurement$213,785
R21 · FY2005 · DK
THE ROLE OF IRON AND HFE GENOTYPE IN LIVER DISEASE$116,006
K24 · FY2005 · DK
Clinical Research Network in Non Alcoholic Steatohepati*$98,540
U01 · FY2005 · DK
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$27,100
M01 · FY2005 · RR
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$4,991
M01 · FY2005 · RR
PIOGLITAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR TREATMENT OF NONALCOHOLIC STE)$1,427
M01 · FY2005 · RR
Clinical Research Network in Non Alcoholic Steatohepati*$489,230
U01 · FY2004 · DK
Complications of elevated transferrin-iron saturation$151,600
R21 · FY2004 · DK
Clinical Research Network in Non Alcoholic Steatohepati*$147,933
U01 · FY2004 · DK
Clinical Research Network in Non Alcoholic Steatohepati*$123,433
U01 · FY2004 · DK
THE ROLE OF IRON AND HFE GENOTYPE IN LIVER DISEASE$116,006
K24 · FY2004 · DK
Siliphos in Hepatitis C$50,774
R21 · FY2004 · AT
Clinical Research Network in Non Alcoholic Steatohepati*$319,872
U01 · FY2003 · DK
Siliphos in Hepatitis C$161,404
R21 · FY2003 · AT
THE ROLE OF IRON AND HFE GENOTYPE IN LIVER DISEASE$116,006
K24 · FY2003 · DK
Clinical Research Network in Non Alcoholic Steatohepati*$319,872
U01 · FY2002 · DK
Siliphos in Hepatitis C$173,433
R21 · FY2002 · AT
THE ROLE OF IRON AND HFE GENOTYPE IN LIVER DISEASE$105,300
K24 · FY2002 · DK
LAMIVUDINE &INTRON A IN PTS W/ HEPATITIS B--NONRESPONDERS$0
M01 · FY2002 · RR
LOBUCAVIR FOR HEPATITIS B$0
M01 · FY2002 · RR
TIPS VS. PARACENTESIS FOR REFRACTORY ASCITES(NASTRA)$0
M01 · FY2002 · RR
LAMIVUDINE IN PTS W/ CHRONIC HEPATITIS B--TREATMENT NAIVE$0
M01 · FY2002 · RR
THE ROLE OF IRON AND HFE GENOTYPE IN LIVER DISEASE$105,300
K24 · FY2001 · DK
LOBUCAVIR FOR HEPATITIS B$0
M01 · FY2001 · RR
TIPS VS. PARACENTESIS FOR REFRACTORY ASCITES(NASTRA)$0
M01 · FY2001 · RR
LAMIVUDINE IN PTS W/ CHRONIC HEPATITIS B--TREATMENT NAIVE$0
M01 · FY2001 · RR
LAMIVUDINE &INTRON A IN PTS W/ HEPATITIS B--NONRESPONDERS$0
M01 · FY2001 · RR
HEMOCHROMATOSIS REGISTRY$72,360
R03 · FY2000 · DK
LAMIVUDINE AND INTRON A IN PATIENTS WITH CHRONIC HEPATITIS B--NONRESPONDERS$3,864
M01 · FY2000 · RR
REBIF FOR HEPATITIS C NON RESPONDERS$3,864
M01 · FY2000 · RR
TIPS VS. PARACENTESIS FOR REFRACTORY ASCITES--NASTRA$3,864
M01 · FY2000 · RR
FAMCICLOVIR FOR THE TREATMENT OF CHRONIC HEPATITIS B$3,864
M01 · FY2000 · RR
IRON REDUCTION AND INTERFERON IN THE THERAPY OF CHRONIC HEPATITIS C INFECTION$3,864
M01 · FY2000 · RR
IRON REDUCTION AND INTERFERON IN THE THERAPY OF CHRONIC HEPATITIS C INFECTION$3,864
M01 · FY2000 · RR
LAMIVUDINE OF PLACEBO IN PATIENTS WITH CHRONIC HEPATITIS B--TREATMENT NAIVE$3,864
M01 · FY2000 · RR
LOBUCAVIR FOR HEPATITIS B$3,864
M01 · FY2000 · RR
LOBUCAVIR FOR HEPATITIS B$3,864
M01 · FY2000 · RR
PATIENT CHARACTERISTICS IN HEREDITARY HEMOCHROMATOSIS$3,864
M01 · FY2000 · RR
PATIENT CHARACTERISTICS IN HEREDITARY HEMOCHROMATOSIS$3,864
M01 · FY2000 · RR
REBIF FOR HEPATITIS C NON RESPONDERS$0
M01 · FY2000 · RR
TIPS VS. PARACENTESIS FOR REFRACTORY ASCITES(NASTRA)$0
M01 · FY2000 · RR
LAMIVUDINE IN PTS W/ CHRONIC HEPATITIS B--TREATMENT NAIVE$0
M01 · FY2000 · RR
LAMIVUDINE &INTRON A IN PTS W/ HEPATITIS B--NONRESPONDERS$0
M01 · FY2000 · RR
FAMCICLOVIR FOR THE TREATMENT OF CHRONIC HEPATITIS B$0
M01 · FY2000 · RR